Ειδήσεις: IMMUNITYBIO | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

31/03 19:36 yahoo.com

Jim Cramer on ImmunityBio: “I Would Encourage You to Own It, Provided You Don’t Own Any Other Spec”

Jim Cramer ImmunityBio stock recommendation biotech investment advice diversification

31/03 18:06 yahoo.com

ImmunityBio Inc. (IBRX) Receives FDA Warning Letter Over Cancer Therapy Claims in Advertisement

ImmunityBio FDA warning letter cancer therapy claims advertising compliance pharmaceutical regulation investor impact

31/03 15:49 investing.com

ImmunityBio stock surges on $100M financing deal

ImmunityBio $100M financing stock surge biotech immunotherapy investor confidence

24/03 17:59 statnews.com

STAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug

FDA Patrick Soon‑Shiong ImmunityBio Anktiva false claims bladder cancer

24/03 16:53 google.com

ImmunityBio shares fall on FDA warning letter over cancer therapy claims in ad - Reuters

ImmunityBio FDA warning cancer therapy stock decline advertising claims biotech

24/03 15:37 investing.com

ImmunityBio stock tumbles after FDA warning on misleading ads

ImmunityBio FDA warning misleading ads stock drop cancer immunotherapy regulatory compliance

20/03 07:03 defenseworld.net

ImmunityBio Highlights ANKTIVA Surge, FDA Papillary Filing and Key 2026 Milestones at Conference

ImmunityBio ANKTIVA FDA filing bladder cancer lung cancer fusion proteins

20/03 07:03 defenseworld.net

ImmunityBio Highlights ANKTIVA Surge, FDA Papillary Filing and Key 2026 Milestones at Conference

ImmunityBio ANKTIVA FDA filing bladder cancer lung cancer fusion proteins

Loading...